CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk

Breast Cancer Research and Treatment

Volumn 110, Issue 2, 2008, Pages 387-393

  Han, Sohee ^a   Lee, Kyoung Mu ^b   Choi, Ji Yeob ^c   Park, Sue Kyung ^a   Lee, Ji Young ^a   Lee, Jong Eun ^d   Noh, Dong Young ^a   Ahn, Sei Hyun ^e   Han, Wonshik ^a   Kim, Dong Hyun ^f   Hong, Yun Chul ^a   Ha, Eunhee ^g   Yoo, Keun Young ^a,h   Kang, Daehee ^a,i  

^a Seoul National University College of Medicine   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d DNA Link Inc   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Hallym University College of Medicine   (South Korea)

^g Ewha Womans University   (South Korea)

^h National Cancer Center   (South Korea)

ⁱ Seoul National University   (South Korea)

Author keywords

Breast cancer; CASP8; Estrogen receptor; Polymorphism; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASP8 GENE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

5' UNTRANSLATED REGIONS; ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CASPASE 8; FEMALE; GENOTYPE; HUMANS; KOREA; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK;

EID: 44849086724     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9730-5     Document Type: Article

References (19)

1. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MWR, Pharoah PDP, Ponder BAJ, Meuth M, Bhattacharyya NP, Cox A (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96:1866-1869
2. Simstein R, Burow M, Parker A, Weldon C, Beckman B (2003) Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med 228:995-1003
3. Ecsedy J, Hunter D (2002) Textbook of cancer epidemiology. In: Adami H-O, Hunter D, Trichopoulos D (eds). Textbook of cancer epidemiology. Oxford University Press, Inc., New York
4. Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ (1999) Structure and chromosome localization of the human CASP8 gene. Gene 226:225-232
5. Jordan LB, Harrison DJ (2003) Apoptosis and cell senescence. In: Crocker J, Murray PG (eds) Molecular biology in cellular pathology. John Wiley & Sons
6. Parton M, Dowsett M, Smith I (2001) Studies of apoptosis in breast cancer. British Med J 322:1528-1532
7. Frank B, Hemminki K, Wappenschmidt B, Meindl A, Klaes R, Schmutzler RK, Bugert P, Untch M, Bartram CR, Burwinkel B (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27:606-609
8. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MWR, Pooley KA, Scollen S, Baynes C, Ponder BAJ, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MRE, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schurmann P, Bogdanova N, Dork T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, Stratton MR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma V-M, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FBL, Veer LJVT, Kang D, Yoo K-Y, Noh D-Y, Ahn S-H, Wedren S, Hall P, Low Y-L, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PDP, Easton DF (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358
9. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, Guo Y, Yang M, Zhang X, Zhang Q, Zeng C, Lin D (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39:605-613
10. Caporaso N (1999) Metabolic polymorphisms and susceptibility to cancer. In: Vineis P, Malats N, Lang M, D'Errico A, Caporaso N, Cuzick J, Boffetta P (eds) Selection of candidate genes for population studies. IARC Scientific Publications, Lyon
11. Haplotype site (2005) Haploview: analysis and visualization of LD and haplotype maps. http://www.bioinformatics.oxfordjournals.org Cited 15 Jan, 2005
12. Hapmap site (2006) GENOMICS: the HapMap gold rush: researchers mine a rich deposit. http://www.sciencemag.org Cited 26 May 2006
13. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1-16
14. Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12:1053-1060
15. Monroe DG, Berger RR, Sanders MM (2002) Tissue-protective effects of estrogen involve regulation of caspase gene expression. Mol Endocrinol 16:1322-1331
16. Razandi M, Pedram A, Levin ER (2000) Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 14:1434-1447
17. Lipponen P (1999) Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer 6:13-16
18. Lipponen P, Aaltomaa S, Kosma VM Syrjänen K (1994) Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A:2068-2073
19. Berardo MD, Elledge RM, de Moor C, Clark GM, Kent Osborne C, Craig Allred D (1998) Bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82:1296-1302